|
Real-time Estimate
Cboe BZX
20:08:46 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.165 USD | -1.71% |
|
-0.63% | +14.91% |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| 08-11 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.71% | -0.63% | +8.22% | -15.96% | +14.91% | -14.36% | -23.11% | -46.72% | -55.81% | 368M | |
| -0.11% | -1.67% | +0.14% | +20.82% | +5.21% | +1.80% | +19.90% | -24.82% | +203.70% | 48.84B | |
| +1.21% | +4.28% | +18.82% | +48.47% | +169.10% | +488.04% | +623.63% | +705.49% | - | 45.44B | |
| +1.67% | +2.70% | +18.80% | +25.89% | +21.45% | +15.55% | +91.13% | +27.25% | +1,185.18% | 41.22B | |
| +0.48% | -0.50% | +18.99% | +40.40% | +7.63% | +26.01% | +13.38% | -4.85% | +222.38% | 39.71B | |
| -2.74% | -2.74% | +11.21% | +8.73% | +13.41% | +17.30% | +56.10% | -13.22% | +144.26% | 32.6B | |
| +1.22% | -1.95% | -0.86% | +5.03% | - | - | - | - | - | 16.25B | |
| -1.12% | -2.44% | +11.89% | +40.42% | +5.17% | +27.61% | +136.58% | +232.94% | +2,027.13% | 16.67B | |
| -0.49% | -0.34% | -2.03% | +15.95% | +11.63% | +3.45% | +29.14% | -40.60% | +88.27% | 14.08B | |
| -1.86% | +0.04% | +28.41% | +88.17% | +41.43% | +79.72% | +41.84% | -32.20% | +238.44% | 13.68B | |
| +0.38% | +2.63% | +2.26% | +49.36% | -6.74% | -4.83% | -32.12% | -29.37% | +124.17% | 13.07B | |
| +2.08% | +8.76% | +44.17% | +92.37% | +79.92% | +69.20% | +80.87% | -36.30% | - | 12.37B | |
| -0.08% | +0.26% | +0.98% | +62.82% | +23.01% | +35.75% | -7.54% | -38.54% | +171.47% | 11.28B | |
| -2.83% | -6.45% | -12.87% | +7.64% | -14.53% | +72.36% | +501.75% | +289.04% | +2,350.00% | 10.57B | |
| -1.92% | -0.06% | +21.69% | +15.58% | +25.70% | +694.50% | +1,615.16% | +54.27% | - | 10.51B | |
| -0.00% | -0.08% | +0.32% | +70.90% | +78.30% | +264.72% | +455.20% | - | - | 10.15B | |
| -0.51% | +6.64% | +17.78% | +56.98% | +81.06% | +181.34% | +726.66% | +238.92% | +1,257.42% | 10.26B | |
| +0.12% | +10.65% | +9.22% | +52.25% | +55.89% | +178.08% | +515.11% | +143.53% | - | 10.1B | |
| +1.12% | +6.53% | +11.50% | -18.59% | -25.37% | +35.94% | +51.97% | +55.25% | +71.28% | 9.74B | |
| -4.34% | -11.08% | +2.29% | +13.53% | -16.14% | -36.88% | - | - | - | 9.32B | |
| Average | -0.47% | +1.09% | +10.55% | +34.04% | +30.05% | +112.38% | +271.98% | +87.06% | +617.53% | 18.81B | |
| Weighted average by Cap. | -0.09% | +0.05% | +11.68% | +34.22% | +37.38% | +115.86% | +225.96% | +120.39% | +582.26% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
